Adams Alex J, Weaver Krystalyn K
Idaho State Board of Pharmacy, Boise, ID.
National Alliance of State Pharmacy Associations (NASPA), Arlington, VA.
Innov Pharm. 2019 Aug 31;10(2). doi: 10.24926/iip.v10i2.1389. eCollection 2019.
Explore the intersection of the Pharmacists' Patient Care Process (PPCP) and state laws in order to identify laws that may impede the delivery of optimal patient care.
A review of the PPCP identified six areas in which state laws can limit full pharmacist engagement: 1) ordering and interpreting laboratory tests; 2) participating in a collaborative practice agreement; 3) independently prescribing certain medications; 4) independently adapting medications; 5) administering medications; and 6) effective delegation. A framework is put forth to organize how these scope of practice matters are interrelated.
For pharmacists to fully engage in the PPCP, state laws must enable full participation. By unleashing pharmacists to fully engage in the process, patient care delivery and outcomes can be improved, and total health care costs can be reduced.
探究药剂师患者护理流程(PPCP)与州法律的交叉点,以识别可能阻碍提供最佳患者护理的法律。
对PPCP的审查确定了州法律可能限制药剂师充分参与的六个领域:1)订购和解读实验室检查;2)参与协作实践协议;3)独立开具某些药物;4)独立调整药物;5)给药;6)有效授权。提出了一个框架来组织这些执业范围事项之间的相互关系。
为使药剂师充分参与PPCP,州法律必须允许充分参与。通过让药剂师充分参与该流程,可以改善患者护理的提供和结果,并降低总体医疗成本。